Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VYNE Therapeutics Inc. | 125,905 | reported | 31 Dec 2025 | tx 49+1,479,586−55,606 |
| Foamix Pharmaceuticals Ltd. | 0 | reported | 09 Mar 2020 | tx 17+319,133−319,133 |
| Satsuma Pharmaceuticals, Inc. | 0 | reported | 08 Jun 2023 | tx 4+70,000−70,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 3,579 | 0.58 USD | |
| 30 Sept 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 3,581 | 0.34 USD | |
| 30 Jun 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 3,581 | 1.65 USD | |
| 02 Jun 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 1,145 | 0.81 USD | |
| 31 Mar 2025 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 8,828 | 1.58 USD | |
| 21 Jan 2025 | GRANT_AWARD | VYNE Therapeutics Inc. | 230,000 | 0.00 USD | deriv |
| 31 Dec 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 4,697 | 3.35 USD | |
| 30 Sept 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 105 | 1.88 USD | |
| 01 Jul 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 143 | 1.92 USD | |
| 01 Apr 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 161 | 3.08 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | |
| 02 Jan 2024 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 161 | 2.28 USD | |
| 01 Jan 2024 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | deriv |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | |
| 13 Dec 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 62,500 | 0.00 USD | deriv |
| 02 Oct 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,154 | 3.83 USD | |
| 30 Jun 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 157 | 4.10 USD | |
| 08 Jun 2023 | OTHER | Satsuma Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 08 Jun 2023 | OTHER | Satsuma Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | VYNE Therapeutics Inc. | 3,664 | 3.46 USD | |
| 31 Mar 2023 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 478 | 3.08 USD | |
| 20 Mar 2023 | PURCHASE | VYNE Therapeutics Inc. | 10,000 | 2.50 USD | |
| 31 Dec 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,813 | 0.15 USD | |
| 30 Sept 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,813 | 0.22 USD | |
| 30 Jun 2022 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,813 | 0.39 USD |